Mind Medicine Inc (MNMD) Q3 2025 Earnings Call Highlights: Strategic Advances and Financial ... [Yahoo! Finance]
Mind Medicine (MindMed) Inc. - Common Shares (MNMD)
Company Research
Source: Yahoo! Finance
For the complete transcript of the earnings call, please refer to the full earnings call transcript Positive Points Mind Medicine Inc ( NASDAQ:MNMD ) successfully completed an underwritten public offering, raising approximately $259 million in gross proceeds, strengthening their balance sheet. The company published full phase 2B clinical trial results in the Journal of the American Medical Association, highlighting the rigor and impact of their clinical results. Enrollment is strong and steady across ongoing pivotal studies, with accelerated timelines for some trials due to faster-than-anticipated enrollment. Mind Medicine Inc ( NASDAQ:MNMD ) is well-positioned for a transformational 2026 with three top-line phase 3 data readouts expected for their generalized anxiety disorder and major depressive disorder programs. The company has a strong cash position, with sufficient funds to support operations into 2028, allowing them to accelerate key initiatives for MM 120 and MM 4
Show less
Read more
Impact Snapshot
Event Time:
MNMD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MNMD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MNMD alerts
High impacting Mind Medicine (MindMed) Inc. - Common Shares news events
Weekly update
A roundup of the hottest topics
MNMD
News
- MindMed Announces New Employee Inducement GrantsBusiness Wire
- Mind Medicine (MindMed) (NASDAQ:MNMD) was upgraded by analysts at Chardan Capital to a "strong-buy" rating.MarketBeat
- Mind Medicine (MindMed) (NASDAQ:MNMD) had its price target raised by analysts at Canaccord Genuity Group Inc. from $16.00 to $25.00. They now have a "buy" rating on the stock.MarketBeat
- Mind Medicine (MindMed) (NASDAQ:MNMD) had its price target lowered by analysts at Royal Bank Of Canada from $21.00 to $20.00. They now have an "outperform" rating on the stock.MarketBeat
- MindMed Reports Q3 2025 Financial Results and Business UpdatesBusiness Wire
MNMD
Earnings
- 11/6/25 - Miss
MNMD
Sec Filings
- 11/14/25 - Form SCHEDULE
- 11/6/25 - Form 10-Q
- 11/6/25 - Form 8-K
- MNMD's page on the SEC website